ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palange, P.
Right arrow Articles by Whipp, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palange, P.
Right arrow Articles by Whipp, B. J.
Eur Respir J 2007; 29:185-209
Copyright ©ERS Journals Ltd 2007

Recommendations on the use of exercise testing in clinical practice

P. Palange1, S. A. Ward2, K-H. Carlsen3, R. Casaburi4, C. G. Gallagher5, R. Gosselink6, D. E. O'Donnell7, L. Puente-Maestu8, A. M. Schols9, S. Singh10 and B. J. Whipp2

1 Servizio di Fisiopatologia Respiratoria, Dipartimento di Medicina Clinica, University of Rome "La Sapienza", Rome, Italy. 2 Institute of Membrane and Systems Biology, University of Leeds, Leeds, and 10 Dept of Respiratory Medicine, Glenfield Hospital, Leicester, UK. 3 Voksentoppen Research Institute and Children's National Hospital of Asthma, Allergy and Chronic Lung Diseases, University of Oslo, Oslo, Norway. 4 Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA, USA. 5 Dept of Respiratory Medicine and the National Referral Centre for Adult Cystic Fibrosis, St Vincent's University Hospital, Dublin, Ireland. 6 Respiratory Rehabilitation and Respiratory Division, University Hospital Gasthuisberg, Leuven, Belgium. 7 Respiratory Investigation Unit, Department of Medicine, Queen's University, Kingston, ON, Canada. 8 Servicio de Neumología, Hospital General Universitario Gregorio Marañon, Madrid, Spain. 9 Dept of Respiratory Medicine, University Hospital Maastricht, Maastricht, The Netherlands.

CORRESPONDENCE: P. Palange, Dipartimento di Medicina Clinica, University of Rome "La Sapienza", v.le Università 37, 00185 Rome, Italy. Fax: 39 064940421. E-mail: paolo.palange{at}uniroma1.it

Keywords: Cardiopulmonary exercise testing, evaluation of interventions, exercise testing, prognosis, walking tests

Received: April 4, 2006
Accepted August 16, 2006

Evidence-based recommendations on the clinical use of cardiopulmonary exercise testing (CPET) in lung and heart disease are presented, with reference to the assessment of exercise intolerance, prognostic assessment and the evaluation of therapeutic interventions (e.g. drugs, supplemental oxygen, exercise training). A commonly used grading system for recommendations in evidence-based guidelines was applied, with the grade of recommendation ranging from A, the highest, to D, the lowest.

For symptom-limited incremental exercise, CPET indices, such as peak O2 uptake (V'O2), V'O2 at lactate threshold, the slope of the ventilation–CO2 output relationship and the presence of arterial O2 desaturation, have all been shown to have power in prognostic evaluation. In addition, for assessment of interventions, the tolerable duration of symptom-limited high-intensity constant-load exercise often provides greater sensitivity to discriminate change than the classical incremental test. Field-testing paradigms (e.g. timed and shuttle walking tests) also prove valuable.

In turn, these considerations allow the resolution of practical questions that often confront the clinician, such as: 1) "When should an evaluation of exercise intolerance be sought?"; 2) "Which particular form of test should be asked for?"; and 3) "What cluster of variables should be selected when evaluating prognosis for a particular disease or the effect of a particular intervention?"




This article has been cited by other articles:


Home page
Eur Respir JHome page
I. Vogiatzis, G. Stratakos, D. Athanasopoulos, O. Georgiadou, S. Golemati, A. Koutsoukou, I. Weisman, C. Roussos, and S. Zakynthinos
Chest wall volume regulation during exercise in COPD patients with GOLD stages II to IV
Eur. Respir. J., July 1, 2008; 32(1): 42 - 52.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. R. Gosker and A. M. W. J. Schols
Fatigued muscles in COPD but no finishing line in sight
Eur. Respir. J., April 1, 2008; 31(4): 693 - 694.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Ofir, P. Laveneziana, K. A. Webb, Y.-M. Lam, and D. E. O'Donnell
Mechanisms of Dyspnea during Cycle Exercise in Symptomatic Patients with GOLD Stage I Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 622 - 629.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. A. Neder
From the authors
Eur. Respir. J., January 1, 2008; 31(1): 220 - 221.
[Full Text] [PDF]


Home page
Eur Respir JHome page
S. Kostianev, K. Terziyski, and B. Marinov
Exercise recovery phase: unrecovered part of the recommendations
Eur. Respir. J., July 1, 2007; 30(1): 181 - 182.
[Full Text] [PDF]


Home page
Eur Respir JHome page
P. Palange and S. A. Ward
From the authors
Eur. Respir. J., July 1, 2007; 30(1): 182 - 183.
[Full Text] [PDF]


Home page
Eur Respir JHome page
P. Palange and S. A. Ward
From the authors
Eur. Respir. J., May 1, 2007; 29(5): 1066 - 1067.
[Full Text] [PDF]


Home page
Eur Respir JHome page
J. E. Cotes and J. W. Reed
Recommendations on the use of exercise testing in clinical practice
Eur. Respir. J., May 1, 2007; 29(5): 1064 - 1066.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the European Respiratory Society.